Assisted Reproductive Technology (ART) Market (By Technology: In-Vitro Fertilization, Artificial Insemination-Intrauterine Insemination, Frozen Embryo Replacement; By End-Use: Hospitals, Fertility Clinics, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2019 - 2026

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Assisted Reproductive Technology (ART)
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Assisted Reproductive Technology (ART) Market By Technology
     1.2.2.1. Global Assisted Reproductive Technology (ART) Market Revenue and Growth Rate Comparison By Technology (2015-2026)
     1.2.2.2. Global Assisted Reproductive Technology (ART) Market Revenue Share By Technology in 2018
     1.2.2.3. In-Vitro Fertilization
     1.2.2.4. Artificial Insemination-Intrauterine Insemination
     1.2.2.5. Frozen Embryo Replacement
   1.2.3. Assisted Reproductive Technology (ART) Market By End-Use
     1.2.3.1. Global Assisted Reproductive Technology (ART) Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
     1.2.3.2. Global Assisted Reproductive Technology (ART) Market Revenue Share By End-Use in 2018
     1.2.3.3. Hospitals
     1.2.3.4. Fertility Clinics
     1.2.3.5. Others
   1.2.4. Assisted Reproductive Technology (ART) Market by Geography
     1.2.4.1. Global Assisted Reproductive Technology (ART) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.4.2. North America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
     1.2.4.3. Europe Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
     1.2.4.4. Asia-Pacific Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
     1.2.4.5. Latin America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)
     1.2.4.6. Middle East and Africa (MEA) Assisted Reproductive Technology (ART) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Assisted Reproductive Technology (ART) Major Manufacturers in 2018

CHAPTER 4. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY TECHNOLOGY
4.1. Global Assisted Reproductive Technology (ART) Revenue By Technology
4.2. In-Vitro Fertilization
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Artificial Insemination-Intrauterine Insemination
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Frozen Embryo Replacement
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY END-USE
5.1. Global Assisted Reproductive Technology (ART) Revenue By End-Use
5.2. Hospitals
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Fertility Clinics
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
6.1. North America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
   6.3.1. U.S. Assisted Reproductive Technology (ART) Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
6.4. Canada
   6.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
7.1. Europe Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
   7.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.4. Germany
   7.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.5. France
   7.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   7.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.6. Spain
   7.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   7.6.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
7.7. Rest of Europe
   7.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   7.7.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
8.1. Asia-Pacific Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
   8.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.4. Japan
   8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.5. India
   8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.6. Australia
   8.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.7. South Korea
   8.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
   8.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   8.8.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
9.1. Latin America Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
   9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.4. Mexico
   9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million) 
   9.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
9.5. Rest of Latin America
   9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY COUNTRY
10.1. Middle East & Africa Assisted Reproductive Technology (ART) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Assisted Reproductive Technology (ART) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
   10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.4. South Africa
   10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
   10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By End-Use, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. Vitro Life
   11.1.1. Company Snapshot
   11.1.2. Overview
   11.1.3. Financial Overview
   11.1.4. Product Portfolio
   11.1.5. Key Developments
   11.1.6. Strategies
11.2. Cooper Surgical Inc.
   11.2.1. Company Snapshot
   11.2.2. Overview
   11.2.3. Financial Overview
   11.2.4. Product Portfolio
   11.2.5. Key Developments
   11.2.6. Strategies
11.3. Genea Limited
   11.3.1. Company Snapshot
   11.3.2. Overview
   11.3.3. Financial Overview
   11.3.4. Product Portfolio
   11.3.5. Key Developments
   11.3.6. Strategies
11.4. Cook Medical
   11.4.1. Company Snapshot
   11.4.2. Overview
   11.4.3. Financial Overview
   11.4.4. Product Portfolio
   11.4.5. Key Developments
   11.4.6. Strategies
11.5. Hamilton Thorne
   11.5.1. Company Snapshot
   11.5.2. Overview
   11.5.3. Financial Overview
   11.5.4. Product Portfolio
   11.5.5. Key Developments
   11.5.6. Strategies
11.6. IVFtech ApS
   11.6.1. Company Snapshot
   11.6.2. Overview
   11.6.3. Financial Overview
   11.6.4. Product Portfolio
   11.6.5. Key Developments
   11.6.6. Strategies
11.7. Irvine scientific
   11.7.1. Company Snapshot
   11.7.2. Overview
   11.7.3. Financial Overview
   11.7.4. Product Portfolio
   11.7.5. Key Developments
   11.7.6. Strategies
11.8. Merck
   11.8.1. Company Snapshot
   11.8.2. Overview
   11.8.3. Financial Overview
   11.8.4. Product Portfolio
   11.8.5. Key Developments
   11.8.6. Strategies
11.9. Nidacon International AB
   11.9.1. Company Snapshot
   11.9.2. Overview
   11.9.3. Financial Overview
   11.9.4. Product Portfolio
   11.9.5. Key Developments
   11.9.6. Strategies
11.10. OvaScience Inc
   11.10.1. Company Snapshot
   11.10.2. Overview
   11.10.3. Financial Overview
   11.10.4. Product Portfolio
   11.10.5. Key Developments
   11.10.6. Strategies
11.11. Thermo Fisher Scientific, Inc
   11.11.1. Company Snapshot
   11.11.2. Overview
   11.11.3. Financial Overview
   11.11.4. Product Portfolio
   11.11.5. Key Developments
   11.11.6. Strategies
11.12. Others
   11.12.1. Company Snapshot
   11.12.2. Overview
   11.12.3. Financial Overview
   11.12.4. Product Portfolio
   11.12.5. Key Developments
   11.12.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
   12.1.1. Initial Data Search
   12.1.2. Secondary Research
   12.1.3. Primary Research
12.2. Assumptions and Scope